Developer docs
API playgroundTry for free, no card

Search company profiles

Incospharm

Full company profile

uuid000pymn

Namestring
Incospharm
Legal namestring
Incospharm Corporation (주)인코스팜
Websiteurl
incospharm.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Incospharm Corporation is a Daejeon, South Korea-based bioactive material developer founded in March 2011 that designs, screens, and commercializes peptide-based and small-molecule cosmetic and pharmaceutical ingredients built around its proprietary AMPed™ (Autophagy Modulating Peptide Derivatives) platform. The company operates as a B2B ingredients supplier, producing a portfolio of more than 20 active ingredients across four technology categories: AMPed™-based peptides (Aquatide™, LiftDerm™, AdipoSOL™, MelaTrepein™, Sebodulin™, Cabelludin™, Serenitide™), recombinant polypeptides (rhEGF, bFGF), natural extracts (PolluxCD™, SOYAMINE, RedoxySense W, Pineapple Ceramide, Wasabi Flavone), and synthetic ingredients (2-GG, Bio-PEC™, DermAging Corrector, ICP De-AGE 1). Underlying technologies include a patented Lipase A enzymatic bioconversion process for producing Bio-PEC™ phyto-endocannabinoids, and the EPOTF platform jointly developed with Kookmin University and MetaPore for scalable exosome manufacturing.

The company monetizes primarily through ingredient supply agreements with global cosmetics manufacturers and brands, including exclusive supply deals for marquee customers such as Galderma (Cetaphil Eye Cream, Biotide/LiftDerm™), Unilever affiliate Carver Korea (AHC eyecream, Aquatide™), Dermalogica (MelaTrepein™), AH&NS Japan (Aquatide™), Dorco Korea, and Skin Reverse Lab. Distribution is executed through direct enterprise sales supplemented by regional channel partners such as J2K Bio (Korea), and pricing is structured around per-unit ingredient concentrations under multi-year contracts rather than public tier pricing. Secondary revenue streams include pharmaceutical drug-candidate licensing using the AMPed™ platform for chronic and intractable skin diseases, and contract research services in skin tissue histology and cosmetics efficacy evaluation using native human skin models. Headcount is 11-50 employees, the company is privately held and venture-certified, and operations are consolidated at a headquarters, R&D center, and factory facility in the Daejeon International Science Business Belt (relocated August 2022).

Short descriptiontext

Incospharm is a South Korea-based bioactive ingredients developer using its proprietary AMPed™ autophagy-modulating peptide platform to supply cosmetic actives and pharmaceutical candidates to global cosmetics brands and manufacturers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDaejeon, South Korea
HQ citystring
Daejeon
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioactive cosmetic ingredients, autophagy modulating peptides, skincare active ingredients, cosmetic polypeptide ingredients, pharmaceutical drug development
Industry4 codes
PRIMARYIMAEABAJ
Personal Care & Cosmetic Ingredients
SECONDARYHLAIACAL
Dermatology Specialty Pharmaceuticals
SECONDARYCRABAAAG
Sensitive Skin & Barrier Repair
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code2 codes
  • Soap and Cleaning Compound Manufacturing32561
  • Pharmaceutical and Medicine Manufacturing3254
SIC code2 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Pharmaceutical Preparations2834
Product category
Bioactive Cosmetic and Pharmaceutical Ingredients
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Bioactive Cosmetic Ingredient Supply
TypeOne Time License
Description

B2B supply of proprietary bioactive ingredients including Aquatide™, MelaTrepein™, LiftDerm™, AdipoSOL™, Sebodulin™, Cabelludin™, and synthetic materials like Bio-PEC™ and 2-GG to cosmetics manufacturers and brands globally.

incospharm.com
2Pharmaceutical Drug Development
TypeLicensing Royalties
Description

Development of new drugs targeting chronic and intractable skin diseases including atopic dermatitis, psoriasis, rosacea, photoaging, and actinic keratosis using AMPed™ platform technology.

incospharm.com
3Contract Research Services
TypeProfessional Services
Description

Tissue sample production services (TMA, histology) and cosmetic efficacy evaluation services using native human skin models for pharmaceutical and cosmetics companies.

incospharm.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Infrastructure, Marketing or Sales, Operations
Pricing details3 tiers
1Cosmetic ingredient concentrations vary by product type
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Aquatide™: 0.01-0.1% for sheet masks, 1-2% for cream/lotion/essence. MelaTrepein™: 2% for brightening products. AdipoSOL™: 1-2% for cream/lotion. Sebodulin™: concentration not specified. Cabelludin™: 1-2% for hair tonic/serum/lotion, 0.01-0.1% for shampoo. Serenitide™: 1-2% for cream/lotion.

incospharm.com
2Synthetic ingredient dosage ranges by application
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Bio-PEC™: 0.1-0.5% for emulsion, 0.01-0.1% for mask sheet. DermAging Corrector: 0.05-0.1% for cream/lotion. ICP De-AGE 1: 1-2% for cream/lotion. 2-GG: 1-2% for cream/lotion/essence.

incospharm.com
3Recombinant growth factor proteins
ModelUnit PricingBilling cadenceMulti-year contract
Notes

rhEGF: 10 ppm for cream/lotion/essence. bFGF: concentration not specified.

incospharm.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Incospharm develops and supplies proprietary bioactive ingredients for cosmetics and pharmaceutical applications, centered on its AMPed™ autophagy-modulating peptide platform. The company sells peptide-based active ingredients (Aquatide™, LiftDerm™, AdipoSOL™, MelaTrepein™, Sebodulin™, Cabelludin™, Serenitide™), cosmetic polypeptides (rhEGF, bFGF), natural extracts (PolluxCD™, SOYAMINE, RedoxySense W, Pineapple Ceramide, Wasabi Flavone), and synthetic ingredients (Bio-PEC™, DermAging Corrector, ICP De-AGE 1, 2-GG) to global cosmetics manufacturers under exclusive supply agreements. It also develops pharmaceutical drug candidates for chronic skin diseases and offers contract research services (skin tissue histology and cosmetic efficacy evaluation).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • First Asian company to win Gold in Innovation Zone Best Ingredient at in-Cosmetics Asia 2016
+2 more records
Product overview1 text field

Incospharm is a skin science-based biotech company developing bioactive ingredients for cosmetics and pharmaceuticals. The product portfolio includes AMPed™-based active ingredients (Aquatide™, LiftDerm™, AdipoSOL™, MelaTrepein™, Sebodulin™, Cabelludin™, Serenitide™), cosmetic polypeptides (rhEGF, bFGF), natural extracts (PolluxCD™, SOYAMINE, RedoxySense W, Pineapple Ceramide, Wasabi Flavone), and synthetic ingredients (2-GG, Bio-PEC™, DermAging Corrector, ICP De-AGE 1). The company offers contract research services including skin tissue histology sample production and cosmetics efficacy evaluation using native skin models. Underlying all products is the proprietary AMPed™ platform technology for autophagy modulation.

Product and service20 records
1Aquatide™
CategoryCosmetic Active Ingredient
Description

AMPed™-based moisturizing ingredient that activates autophagy and SIRT1 to slow skin aging, enhance ceramide synthesis, and strengthen skin barrier function. For cosmetics manufacturers formulating skin moisturization, anti-aging, and barrier-enhancing products.

2LiftDerm™ (Hybrid Peptide BIO / Biotide)
CategoryCosmetic Active Ingredient
Description

Peptide complex that improves epidermis and dermis structure through collagen synthesis stimulation and dermal-epidermal junction enhancement, reducing fine wrinkles. For anti-aging cosmetic formulations.

3AdipoSOL™
CategoryCosmetic Active Ingredient
Description

Anti-photoaging ingredient that protects skin from environmental stress through autophagy activation and adiponectin induction, providing redness relief and UV protection. For anti-photoaging cosmetic formulations.

4MelaTrepein™
CategoryCosmetic Active Ingredient
Description

Dual-action anti-hyperpigmentation agent that breaks down melanosomes via autophagy activation and inhibits melanosome uptake simultaneously. For skin brightening cosmetic formulations.

5Sebodulin™ (Seboduin)
CategoryCosmetic Active Ingredient
Description

First sebogenesis-modulating ingredient based on autophagy signaling that helps restore healthy hydrolipidic film on skin with anti-inflammatory activity against C.acne. For acne-troubled and sebum-control cosmetic formulations.

6Cabelludin™
CategoryCosmetic Active Ingredient
Description

Proprietary peptide complex for scalp care that activates autophagy and β-catenin signaling to promote hair growth, reduce inflammation, and improve scalp environment. For scalp tonic/serum/lotion and shampoo formulations.

7Serenitide™
CategoryCosmetic Active Ingredient
Description

Triple-mode action peptide for sensitive and irritated skin that reduces UV and blue light-induced DNA damage and alleviates local allergic responses. For sensitive skin cream/lotion formulations.

8rhEGF (rh-Oligopeptide-1)
CategoryCosmetic Polypeptide
Description

Recombinant human epidermal growth factor (>95% purity) that stimulates growth and differentiation of fibroblasts and keratinocytes, supporting wound healing and skin tissue regeneration. For advanced skin regeneration cosmetic formulations.

9bFGF (rh-Polypeptide-1)
CategoryCosmetic Polypeptide
Description

Basic fibroblast growth factor that promotes skin regeneration by activating keratinocytes and fibroblasts, stimulating collagen, elastin, and hyaluronic acid synthesis. For anti-aging and regenerative cosmetic formulations.

10PolluxCD™ (Crepidiastrum Denticulatum Leaf/Stem Extract)
CategoryNatural Extract
Description

Plant extract that protects skin against air-pollution stress from fine dust, heavy metals, and UVB radiation, preventing pollution-induced skin aging. For anti-pollution and protective cosmetic formulations.

11SOYAMINE (Soybean Germ Extract)
CategoryNatural Extract
Description

Soybean germ extract rich in polyamine that promotes collagen synthesis, improves skin elasticity and tone, reduces wrinkles, and minimizes pores. For anti-aging and pore-care cosmetic formulations.

12RedoxySense W (Rice Ferment Filtrate / SAKE)
CategoryNatural Extract
Description

Rice ferment filtrate containing high-concentration thioredoxin (TRX) providing antioxidant and anti-inflammatory effects for atopic dermatitis and various skin conditions. For soothing and antioxidant cosmetic formulations.

13Pineapple Ceramide (Ananas Sativus Fruit Extract)
CategoryNatural Extract
Description

Pineapple fruit extract rich in glucosylceramide and vitamin E/K precursors that strengthens skin barrier and improves skin tone and texture. For barrier-strengthening cosmetic formulations.

14Wasabi Flavone (Wasabia Japonica Leaf Extract)
CategoryNatural Extract
Description

Wasabi leaf extract enhanced with isosaponarin that promotes collagen synthesis, improves wrinkles, texture, and elasticity, with antimicrobial benefits. For anti-aging cosmetic formulations.

152-GG (Glyceryl Glucoside)
CategorySynthetic Ingredient
Description

Plant-derived ingredient combining glycerol and glucose that enhances aquaporin-3 expression for skin moisturization and barrier function, with antioxidant and anti-inflammatory properties. For moisturizing cream/lotion/essence formulations.

16Bio-PEC™ (Biosynthesis Phyto-Endocannabinoids)
CategorySynthetic Ingredient
Description

Enzyme-catalyzed bioconversion-processed plant oils providing eco-friendly cannabinoid-like effects without regulatory issues, activating skin cannabinoid receptors for soothing and anti-inflammation. For calming emulsion and mask sheet formulations.

17DermAging Corrector
CategorySynthetic Ingredient
Description

Senolytic anti-aging ingredient with benzoyl tryptamine that induces selective elimination of senescent cells and reduces SASP-related skin damages. For anti-aging cream/lotion formulations.

18ICP De-AGE 1 (N-Dichloroacetyl Tryptamine)
CategorySynthetic Ingredient
Description

Dual-action anti-glycation ingredient that prevents AGEs formation and accelerates elimination of pre-formed advanced glycation end-products. For anti-glycation cream/lotion formulations.

19Cosmetics Efficacy Evaluation Service
CategoryContract Research Service
Description

Efficacy evaluation service using native human skin models for measuring moisturizing, anti-aging, brightening, anti-wrinkle, and skin barrier functions with quantitative and qualitative protein analysis. For cosmetics and pharmaceutical R&D organizations.

20Skin Tissue Histology Sample Production Service
CategoryContract Research Service
Description

Professional skin tissue sample production service including TMA blocks, paraffin blocks, H&E and specialized staining (Masson's Trichrome, Fontana Masson, Toluidine blue, IHC), and image analysis for histological evaluation of skin changes and protein expression. For pharmaceutical and cosmetics R&D organizations.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-12-28
Description

Joint development of EPOTF technology for mass production of exosomes. Academic-industry collaboration combining university research expertise with company technology development capabilities.

2MetaPore (Korea)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-12-28
Description

Joint development partner for EPOTF technology for mass production of exosomes using innovative filtration technique. Three-way collaboration with Kookmin University.

incospharm.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-06-13
Description

Distribution sales agreement for cosmetics ingredient portfolio. J2K Bio serves as the exclusive distributor for Incospharm's cosmetic ingredient products in the Korean market.

Strategic tierSecondaryTypeStrategic or Co-development PartnerAnnounced on2022-01-20
Description

Business cooperation agreement for collaborative development in pharmaceutical and cosmetics sectors.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2021-07-01
Description

Supply agreement for MelaTrepein™ ingredient for skin brightening products in the professional skincare market segment.

Strategic tierSecondaryTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2019-06-01
Description

Exclusive supply of Aquatide 5000 for men's shaving products, targeting the growing male grooming market segment.

7Skin Reverse Lab Corp. (Korea)
Strategic tierSecondaryTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2019-01-01
Description

Supply agreement for Aquatide5000 for skin care product development and commercialization.

incospharm.com
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2017-09-01
Description

Exclusive supply agreement for Aquatide™ ingredient for AHC eyecream products. Carver Korea is an affiliate of global consumer goods giant Unilever, providing strategic access to major retail channels and brand visibility.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2017-09-01
Description

Exclusive supply of Biotide (LiftDerm™) for Cetaphil Eye Cream products. Galderma is a leading global dermatology company, providing access to pharmaceutical-grade cosmetics market.

10AH&NS Corp. (Japan)
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2017-01-01
Description

Exclusive supply agreement for Aquatide™ for the Japanese market, expanding geographic reach to one of the world's largest cosmetics markets.

incospharm.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

French specialty bioactive ingredient developer for skincare, now part of Croda. Highly comparable as a peptide- and active-based cosmetic ingredient supplier serving global brand owners, but with substantially larger scale and R&D resources.

2Lucas Meyer Cosmetics (IFF)
TypeBroad incumbent
Description

Specialty cosmetic active ingredient maker acquired by IFF. Directly comparable B2B model selling bioactives to cosmetics brands, but with broader portfolio and global commercialization infrastructure.

TypeDirect peer
Description

Spanish-origin developer of peptide-based active ingredients for skincare (e.g., Argireline). Closely comparable as a boutique peptide-focused cosmetic active supplier with global brand customers.

4Mibelle Biochemistry
TypeDirect peer
Description

Swiss developer of bioactive cosmetic ingredients using novel mechanisms (plant cell culture, peptides). Directly comparable in technology positioning, ingredient portfolio model, and target customer base.

TypeBroad incumbent
Description

Swiss fragrance/beauty major with a sizable active ingredients business for skincare. Comparable end-customer overlap but with vastly larger product breadth, scale, and regulatory reach.

TypeBroad incumbent
Description

Global specialty chemicals leader with a major personal care actives division (including Sederma). Comparable customer base and ingredient category but operates at much larger scale across many chemistry platforms.

TypeBroad incumbent
Description

German specialty chemicals major with significant cosmetic actives portfolio. Comparable in selling differentiated ingredients to cosmetics brands, but with broader technology base and global footprint.

TypeBroad incumbent
Description

One of the largest global suppliers of cosmetic active ingredients, including peptides and bioactives. Comparable end-market but incomparable scale; sets the competitive ceiling for boutique actives suppliers.

9Corum Inc.
TypeRegional player
Description

Taiwanese specialty ingredient developer focused on peptides and bioactives for skincare. Comparable in product type and customer profile, but primarily serves Asia-Pacific rather than competing directly in Incospharm's global account footprint.

TypeBroad incumbent
Description

Global personal care ingredients giant with bioactive and skin-active portfolio including peptides. Comparable in ingredient category and global brand customer base, but operates at significantly larger scale and breadth.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Incospharm

Bioactive Cosmetic and Pharmaceutical Ingredientsincospharm.com

Incospharm is a South Korea-based bioactive ingredients developer using its proprietary AMPed™ autophagy-modulating peptide platform to supply cosmetic actives and pharmaceutical candidates to global cosmetics brands and manufacturers.

What Incospharm does

Incospharm Corporation is a Daejeon, South Korea-based bioactive material developer founded in March 2011 that designs, screens, and commercializes peptide-based and small-molecule cosmetic and pharmaceutical ingredients built around its proprietary AMPed™ (Autophagy Modulating Peptide Derivatives) platform. The company operates as a B2B ingredients supplier, producing a portfolio of more than 20 active ingredients across four technology categories: AMPed™-based peptides (Aquatide™, LiftDerm™, AdipoSOL™, MelaTrepein™, Sebodulin™, Cabelludin™, Serenitide™), recombinant polypeptides (rhEGF, bFGF), natural extracts (PolluxCD™, SOYAMINE, RedoxySense W, Pineapple Ceramide, Wasabi Flavone), and synthetic ingredients (2-GG, Bio-PEC™, DermAging Corrector, ICP De-AGE 1). Underlying technologies include a patented Lipase A enzymatic bioconversion process for producing Bio-PEC™ phyto-endocannabinoids, and the EPOTF platform jointly developed with Kookmin University and MetaPore for scalable exosome manufacturing.

The company monetizes primarily through ingredient supply agreements with global cosmetics manufacturers and brands, including exclusive supply deals for marquee customers such as Galderma (Cetaphil Eye Cream, Biotide/LiftDerm™), Unilever affiliate Carver Korea (AHC eyecream, Aquatide™), Dermalogica (MelaTrepein™), AH&NS Japan (Aquatide™), Dorco Korea, and Skin Reverse Lab. Distribution is executed through direct enterprise sales supplemented by regional channel partners such as J2K Bio (Korea), and pricing is structured around per-unit ingredient concentrations under multi-year contracts rather than public tier pricing. Secondary revenue streams include pharmaceutical drug-candidate licensing using the AMPed™ platform for chronic and intractable skin diseases, and contract research services in skin tissue histology and cosmetics efficacy evaluation using native human skin models. Headcount is 11-50 employees, the company is privately held and venture-certified, and operations are consolidated at a headquarters, R&D center, and factory facility in the Daejeon International Science Business Belt (relocated August 2022).

Incospharm firmographics

Firmographics
Name
Incospharm
Legal name
Incospharm Corporation (주)인코스팜
Website
https://incospharm.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Incospharm is a South Korea-based bioactive ingredients developer using its proprietary AMPed™ autophagy-modulating peptide platform to supply cosmetic actives and pharmaceutical candidates to global cosmetics brands and manufacturers.
Ownership category
akta.pro rank

Incospharm industry classification

Industry
Product category
Bioactive Cosmetic and Pharmaceutical Ingredients
NAICS
Soap and Cleaning Compound Manufacturing (32561), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYIMAEABAJ
Personal Care & Cosmetic Ingredients
SECONDARYHLAIACAL
Dermatology Specialty Pharmaceuticals
SECONDARYCRABAAAG
Sensitive Skin & Barrier Repair
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Bioactive cosmetic ingredients
  • Autophagy modulating peptides
  • Skincare active ingredients
  • Cosmetic polypeptide ingredients
  • Pharmaceutical drug development

Where Incospharm is headquartered

Location

Headquarters

HQ city
Daejeon
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

Incospharm business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Bioactive Cosmetic Ingredient Supply: B2B supply of proprietary bioactive ingredients including Aquatide™, MelaTrepein™, LiftDerm™, AdipoSOL™, Sebodulin™, Cabelludin™, and synthetic materials like Bio-PEC™ and 2-GG to cosmetics manufacturers and brands globally.
  2. Pharmaceutical Drug Development: Development of new drugs targeting chronic and intractable skin diseases including atopic dermatitis, psoriasis, rosacea, photoaging, and actinic keratosis using AMPed™ platform technology.
  3. Contract Research Services: Tissue sample production services (TMA, histology) and cosmetic efficacy evaluation services using native human skin models for pharmaceutical and cosmetics companies.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractCosmetic ingredient concentrations vary by product type
Unit PricingMulti-year contractSynthetic ingredient dosage ranges by application
Unit PricingMulti-year contractRecombinant growth factor proteins

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Incospharm product offering

Product offering

Core offering

Incospharm develops and supplies proprietary bioactive ingredients for cosmetics and pharmaceutical applications, centered on its AMPed™ autophagy-modulating peptide platform. The company sells peptide-based active ingredients (Aquatide™, LiftDerm™, AdipoSOL™, MelaTrepein™, Sebodulin™, Cabelludin™, Serenitide™), cosmetic polypeptides (rhEGF, bFGF), natural extracts (PolluxCD™, SOYAMINE, RedoxySense W, Pineapple Ceramide, Wasabi Flavone), and synthetic ingredients (Bio-PEC™, DermAging Corrector, ICP De-AGE 1, 2-GG) to global cosmetics manufacturers under exclusive supply agreements. It also develops pharmaceutical drug candidates for chronic skin diseases and offers contract research services (skin tissue histology and cosmetic efficacy evaluation).

Product overview

Incospharm is a skin science-based biotech company developing bioactive ingredients for cosmetics and pharmaceuticals. The product portfolio includes AMPed™-based active ingredients (Aquatide™, LiftDerm™, AdipoSOL™, MelaTrepein™, Sebodulin™, Cabelludin™, Serenitide™), cosmetic polypeptides (rhEGF, bFGF), natural extracts (PolluxCD™, SOYAMINE, RedoxySense W, Pineapple Ceramide, Wasabi Flavone), and synthetic ingredients (2-GG, Bio-PEC™, DermAging Corrector, ICP De-AGE 1). The company offers contract research services including skin tissue histology sample production and cosmetics efficacy evaluation using native skin models. Underlying all products is the proprietary AMPed™ platform technology for autophagy modulation.

Differentiator

Problem solved

Functional benefit

Products and services

  • Aquatide™ AMPed™-based moisturizing ingredient that activates autophagy and SIRT1 to slow skin aging, enhance ceramide synthesis, and strengthen skin barrier function. For cosmetics manufacturers formulating skin moisturization, anti-aging, and barrier-enhancing products.
  • LiftDerm™ (Hybrid Peptide BIO / Biotide) Peptide complex that improves epidermis and dermis structure through collagen synthesis stimulation and dermal-epidermal junction enhancement, reducing fine wrinkles. For anti-aging cosmetic formulations.
  • AdipoSOL™ Anti-photoaging ingredient that protects skin from environmental stress through autophagy activation and adiponectin induction, providing redness relief and UV protection. For anti-photoaging cosmetic formulations.
  • MelaTrepein™ Dual-action anti-hyperpigmentation agent that breaks down melanosomes via autophagy activation and inhibits melanosome uptake simultaneously. For skin brightening cosmetic formulations.
  • Sebodulin™ (Seboduin) First sebogenesis-modulating ingredient based on autophagy signaling that helps restore healthy hydrolipidic film on skin with anti-inflammatory activity against C.acne. For acne-troubled and sebum-control cosmetic formulations.
  • Cabelludin™ Proprietary peptide complex for scalp care that activates autophagy and β-catenin signaling to promote hair growth, reduce inflammation, and improve scalp environment. For scalp tonic/serum/lotion and shampoo formulations.
  • Serenitide™ Triple-mode action peptide for sensitive and irritated skin that reduces UV and blue light-induced DNA damage and alleviates local allergic responses. For sensitive skin cream/lotion formulations.
  • rhEGF (rh-Oligopeptide-1) Recombinant human epidermal growth factor (>95% purity) that stimulates growth and differentiation of fibroblasts and keratinocytes, supporting wound healing and skin tissue regeneration. For advanced skin regeneration cosmetic formulations.
  • bFGF (rh-Polypeptide-1) Basic fibroblast growth factor that promotes skin regeneration by activating keratinocytes and fibroblasts, stimulating collagen, elastin, and hyaluronic acid synthesis. For anti-aging and regenerative cosmetic formulations.
  • PolluxCD™ (Crepidiastrum Denticulatum Leaf/Stem Extract) Plant extract that protects skin against air-pollution stress from fine dust, heavy metals, and UVB radiation, preventing pollution-induced skin aging. For anti-pollution and protective cosmetic formulations.
  • SOYAMINE (Soybean Germ Extract) Soybean germ extract rich in polyamine that promotes collagen synthesis, improves skin elasticity and tone, reduces wrinkles, and minimizes pores. For anti-aging and pore-care cosmetic formulations.
  • RedoxySense W (Rice Ferment Filtrate / SAKE) Rice ferment filtrate containing high-concentration thioredoxin (TRX) providing antioxidant and anti-inflammatory effects for atopic dermatitis and various skin conditions. For soothing and antioxidant cosmetic formulations.
  • Pineapple Ceramide (Ananas Sativus Fruit Extract) Pineapple fruit extract rich in glucosylceramide and vitamin E/K precursors that strengthens skin barrier and improves skin tone and texture. For barrier-strengthening cosmetic formulations.
  • Wasabi Flavone (Wasabia Japonica Leaf Extract) Wasabi leaf extract enhanced with isosaponarin that promotes collagen synthesis, improves wrinkles, texture, and elasticity, with antimicrobial benefits. For anti-aging cosmetic formulations.
  • 2-GG (Glyceryl Glucoside) Plant-derived ingredient combining glycerol and glucose that enhances aquaporin-3 expression for skin moisturization and barrier function, with antioxidant and anti-inflammatory properties. For moisturizing cream/lotion/essence formulations.
  • Bio-PEC™ (Biosynthesis Phyto-Endocannabinoids) Enzyme-catalyzed bioconversion-processed plant oils providing eco-friendly cannabinoid-like effects without regulatory issues, activating skin cannabinoid receptors for soothing and anti-inflammation. For calming emulsion and mask sheet formulations.
  • DermAging Corrector Senolytic anti-aging ingredient with benzoyl tryptamine that induces selective elimination of senescent cells and reduces SASP-related skin damages. For anti-aging cream/lotion formulations.
  • ICP De-AGE 1 (N-Dichloroacetyl Tryptamine) Dual-action anti-glycation ingredient that prevents AGEs formation and accelerates elimination of pre-formed advanced glycation end-products. For anti-glycation cream/lotion formulations.
  • Cosmetics Efficacy Evaluation Service Efficacy evaluation service using native human skin models for measuring moisturizing, anti-aging, brightening, anti-wrinkle, and skin barrier functions with quantitative and qualitative protein analysis. For cosmetics and pharmaceutical R&D organizations.
  • Skin Tissue Histology Sample Production Service Professional skin tissue sample production service including TMA blocks, paraffin blocks, H&E and specialized staining (Masson's Trichrome, Fontana Masson, Toluidine blue, IHC), and image analysis for histological evaluation of skin changes and protein expression. For pharmaceutical and cosmetics R&D organizations.

Quantifiable outcome

  • First Asian company to win Gold in Innovation Zone Best Ingredient at in-Cosmetics Asia 2016
  • +2 more outcomes

Companies that use Incospharm

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Incospharm technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature12 records

Incospharm partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and secondary.

  • Kookmin University (Korea)coreStrategic or Co-development Partner · 28 December 2023Joint development of EPOTF technology for mass production of exosomes. Academic-industry collaboration combining university research expertise with company technology development capabilities.
  • MetaPore (Korea)coreStrategic or Co-development Partner · 28 December 2023Joint development partner for EPOTF technology for mass production of exosomes using innovative filtration technique. Three-way collaboration with Kookmin University.
  • J2K Bio (Korea)coreChannel Partner/ Reseller/ Distributor · 13 June 2023Distribution sales agreement for cosmetics ingredient portfolio. J2K Bio serves as the exclusive distributor for Incospharm's cosmetic ingredient products in the Korean market.
  • Medica Korea (Korea)secondaryStrategic or Co-development Partner · 20 January 2022Business cooperation agreement for collaborative development in pharmaceutical and cosmetics sectors.
  • Dermalogica LLC. (USA)coreOEM/ Whitelabel/ Licensing Partner · 1 July 2021Supply agreement for MelaTrepein™ ingredient for skin brightening products in the professional skincare market segment.
  • Dorco Corp. (Korea)secondaryOEM/ Whitelabel/ Licensing Partner · 1 June 2019Exclusive supply of Aquatide 5000 for men's shaving products, targeting the growing male grooming market segment.
  • Skin Reverse Lab Corp. (Korea)secondaryOEM/ Whitelabel/ Licensing Partner · 1 January 2019Supply agreement for Aquatide5000 for skin care product development and commercialization.
  • Carver Korea Corp. (Unilever Affiliate)coreOEM/ Whitelabel/ Licensing Partner · 1 September 2017Exclusive supply agreement for Aquatide™ ingredient for AHC eyecream products. Carver Korea is an affiliate of global consumer goods giant Unilever, providing strategic access to major retail channels and brand visibility.
  • Galderma (Switzerland)coreOEM/ Whitelabel/ Licensing Partner · 1 September 2017Exclusive supply of Biotide (LiftDerm™) for Cetaphil Eye Cream products. Galderma is a leading global dermatology company, providing access to pharmaceutical-grade cosmetics market.
  • AH&NS Corp. (Japan)coreOEM/ Whitelabel/ Licensing Partner · 1 January 2017Exclusive supply agreement for Aquatide™ for the Japanese market, expanding geographic reach to one of the world's largest cosmetics markets.

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

Incospharm competitors and assessment

Company assessment

Broad incumbents

  • Sederma (Croda International): French specialty bioactive ingredient developer for skincare, now part of Croda. Highly comparable as a peptide- and active-based cosmetic ingredient supplier serving global brand owners, but with substantially larger scale and R&D resources.
  • Lucas Meyer Cosmetics (IFF): Specialty cosmetic active ingredient maker acquired by IFF. Directly comparable B2B model selling bioactives to cosmetics brands, but with broader portfolio and global commercialization infrastructure.
  • Givaudan Active Beauty: Swiss fragrance/beauty major with a sizable active ingredients business for skincare. Comparable end-customer overlap but with vastly larger product breadth, scale, and regulatory reach.
  • Croda International: Global specialty chemicals leader with a major personal care actives division (including Sederma). Comparable customer base and ingredient category but operates at much larger scale across many chemistry platforms.
  • Evonik (Care Solutions / Personal Care): German specialty chemicals major with significant cosmetic actives portfolio. Comparable in selling differentiated ingredients to cosmetics brands, but with broader technology base and global footprint.
  • BASF Personal Care: One of the largest global suppliers of cosmetic active ingredients, including peptides and bioactives. Comparable end-market but incomparable scale; sets the competitive ceiling for boutique actives suppliers.
  • DSM-Firmenich (Personal Care & Aroma): Global personal care ingredients giant with bioactive and skin-active portfolio including peptides. Comparable in ingredient category and global brand customer base, but operates at significantly larger scale and breadth.

Direct peers

  • Lipotec (Lubrizol Life Science): Spanish-origin developer of peptide-based active ingredients for skincare (e.g., Argireline). Closely comparable as a boutique peptide-focused cosmetic active supplier with global brand customers.
  • Mibelle Biochemistry: Swiss developer of bioactive cosmetic ingredients using novel mechanisms (plant cell culture, peptides). Directly comparable in technology positioning, ingredient portfolio model, and target customer base.

Regional players

  • Corum Inc. Taiwanese specialty ingredient developer focused on peptides and bioactives for skincare. Comparable in product type and customer profile, but primarily serves Asia-Pacific rather than competing directly in Incospharm's global account footprint.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Incospharm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Incospharm leadership team

Management profile

Number of profiles

Profiles1 record

Incospharm funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Incospharm M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Incospharm

What does Incospharm do?

Incospharm develops and supplies proprietary bioactive ingredients for cosmetics and pharmaceutical applications, centered on its AMPed™ autophagy-modulating peptide platform. The company sells peptide-based active ingredients (Aquatide™, LiftDerm™, AdipoSOL™, MelaTrepein™, Sebodulin™, Cabelludin™, Serenitide™), cosmetic polypeptides (rhEGF, bFGF), natural extracts (PolluxCD™, SOYAMINE, RedoxySense W, Pineapple Ceramide, Wasabi Flavone), and synthetic ingredients (Bio-PEC™, DermAging Corrector, ICP De-AGE 1, 2-GG) to global cosmetics manufacturers under exclusive supply agreements. It also develops pharmaceutical drug candidates for chronic skin diseases and offers contract research services (skin tissue histology and cosmetic efficacy evaluation).

Is Incospharm a public or private company?

Incospharm is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Incospharm founded?

Incospharm was founded in 2011. It employs 11 to 50 people.

Where is Incospharm based?

Incospharm is headquartered in Daejeon, South Korea, in the Asia region.

How does Incospharm make money?

Three revenue lines are on record. Bioactive Cosmetic Ingredient Supply is the primary driver. The others are pharmaceutical Drug Development and contract Research Services.

Who are Incospharm's main competitors?

Broad incumbents on record are Sederma (Croda International), Lucas Meyer Cosmetics (IFF), Givaudan Active Beauty, Croda International, Evonik (Care Solutions / Personal Care), BASF Personal Care and DSM-Firmenich (Personal Care & Aroma). Direct peers are Lipotec (Lubrizol Life Science) and Mibelle Biochemistry. Corum Inc. is listed as a regional player.

Does Incospharm have an API?

No public API is recorded for Incospharm.

What industry is Incospharm in?

Incospharm's product category is Bioactive Cosmetic and Pharmaceutical Ingredients. Its primary akta.pro industry code is IMAEABAJ, Personal Care & Cosmetic Ingredients, with a secondary code of HLAIACAL, Dermatology Specialty Pharmaceuticals. Its NAICS code is 32561 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals